Plus, news about Amgen, Tenax Therapeutics and Celon Pharma:
Fulcrum Therapeutics loses a partner: Bristol Myers Squibb’s MyoKardia unit told Fulcrum …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.